Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study-Reference-Cited by-同舟云学术

Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study

Published:2019-03-05 Issue:7 Volume:120 Page:689-696
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Tomita Naohiro,Kunieda Katsuyuki,Maeda Atsuyuki,Hamada Chikuma,Yamanaka Takeharu,Sato Toshihiko,Yoshida Kazuhiro,Boku Narikazu,Nezu Riichiro,Yamaguchi Shigeki,Mishima Hideyuki,Sadahiro Sotaro,Muro Kei,Ishiguro Megumi,Sakamoto Junichi,Saji Shigetoyo,Maehara Yoshihiko

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-019-0410-0.pdf

Reference23 articles.

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386 (2015).

2. Projected Cancer Statistics, 2017. Cancer Information Service http://ganjoho.jp/en/public/statistics/short_pred.html Accessed 20 Dec 2017.

3. Gray, R. G. et al. QUASAR Collaborative Group: Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet 355, 1588–1596 (2000).

4. Haller, D. G. et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. J. Clin. Oncol. 23, 8671–8678 (2005).

5. André, T. et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: Results of a randomized trial. J. Clin. Oncol. 21, 2896–2903 (2003).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalizing adjuvant therapy for patients with colorectal cancer;Nature Reviews Clinical Oncology;2023-11-24

2. Feasibility and Safety of Adjuvant Chemotherapy for Resected Colorectal Cancer in Patients With Renal Insufficiency: A Pooled Analysis of Individual Patient Data from Five Japanese Large-scale Clinical Trials;Anticancer Research;2023-06-23

3. SLC25A24, a potential and novel biomarker for diagnosing colorectal cancer;2023-05-19

4. The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of adjuvant treatment and survival;International Journal of Clinical Oncology;2023-04-11

5. Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database;Current Oncology;2023-01-10